The Psychiatrist (2008) 32: 419-422. doi: 10.1192/pb.bp.107.018515
© 2008 The Royal College of Psychiatrists
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Kingdon, D.
Right arrow Articles by Turkington, D.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Kingdon, D.
Right arrow Articles by Turkington, D.

Destigmatising schizophrenia: does changing terminology reduce negative attitudes?

David Kingdon, Professor of Mental Health Care Delivery

*University of Southampton, Royal South Hants Hospital, Southampton SO14 0YG, email: dgk{at}soton.ac.uk

Selvarej Vincent, Lecturer, Sylvia Vincent, Research Assistant and Yoshihiro Kinoshita, PhD Student

University of Southampton

Douglas Turkington, Professor of Psychosocial Psychiatry

University of Newcastle, Royal Victoria Infirmary, Newcastle

Declaration of interest

None. National Health Service research and development support funding.


arrow
Abstract
 
AIMS AND METHOD

Health promotion campaigns using current terminology have had limited success in reducing stigma to schizophrenia. Terminology and subgroups based on historical precedent, clinical experience and psychosocial research have been developed to provide an alternative to existing terminology, and the attitudes to schizophrenia and alternative terminology of a sample of medical students (n=241) were compared.

RESULTS

Overall attitudes were significantly less negative with the alternatives. The students were less negative about the potential for recovery in relation to all the subgroups than for schizophrenia. Concerns about dangerousness were also less prominent with the exception of the drug-related group.

CLINICAL IMPLICATIONS

Subgroups and alternative terminology should be further explored in programmes to destigmatise schizophrenia.


arrow
Introduction
 
Antipsychotic medication and psychosocial interventions have been found to substantially improve the prospect of recovery in schizophrenia for many. However, a major impediment to this is social exclusion by the general population (Kingdon et al, 2006). Health promotion campaigns have had marginal impact on this (Crisp et al, 2004) and concerns about the dangerousness of people with schizophrenia to society have, if anything, hardened (National Statistics, 2003). This is not simply caused by lack of knowledge as campaigns to promote a biological model of schizophrenia have been successful in ‘increasing the public’s tendency to endorse biological causes’ (Angermeyer & Matschinger, 2005). Paradoxically, however, such campaigns may have the effect of increasing social distancing by the general population from people with schizophrenia (Angermeyer & Matschinger, 2005).

An alternative approach is to associate schizophrenia with evidence from psychosocial research which has found that trauma (Read et al, 2003), hallucinogenic drug use (Hall, 2006) and stress-sensitivity (Myin-Germeys et al, 2005) are significant risk factors. Approaches using cognitive therapy have found such associations valuable in directing formulation-based therapeutic interventions (Kingdon & Turkington, 2005). Using such associations has also proved meaningful and more acceptable to service users and carers who dislike the very term ‘schizophrenia’ (Kingdon et al, 2008) and are proposing alternatives (Teskey, 2006). Renaming schizophrenia is controversial and concern has been expressed that it would not address the core problem that is ‘the public’s ignorance and fear’ (Lieberman & First, 2007). Nevertheless, attention to naming cannot be dismissed - the public relations industry devotes substantial resources to the importance of presentation of services and products (Kingdon et al, 2007).

Describing more precisely Bleuler’s ‘group of schizophrenias’ (Bleuler, 1911) would allow research, training and terminology to be tailored to each of them. Kraepelin (1919) made an attempt to do this - he famously delineated manic depressive insanity from dementia praecox but also differentiated it from paranoid states where behaviour was only abnormal in so far as it was the outcome of delusions. He also distinguished dementia praecox from hysteria but then reclaimed those in whom hallucinations were persistent as he believed this gave ‘decisive evidence for dementia praecox’. Schneider’s emphasis on defining schizophrenia based on the nature of symptoms rather than their content (Schneider, 1959) initially led to a tighter definition of schizophrenia. However, first-rank symptoms have proved to be less specific than initially hoped (Carpenter et al, 1973) - for example, they have been demonstrated to occur in association with trauma (Ross & Joshi, 1992) and in individuals whose initial psychotic experience was directly from the effects of stimulant and hallucinogenic drugs. The inclusion of this group under the schizophrenia rubric became of increasing importance from the 1960s onwards, leading to a substantial broadening of this diagnostic category.

Thus, a combination of clinical observation, psychosocial research and historical precedent has contributed to the delineation of four possible subgroups of schizophrenia. Kraepelin’s dementia praecox has survived in classification systems as disorganised schizophrenia (DSM-IV), nuclear schizophrenia and hebephrenia. This has been refined further as the ‘deficit state’ (Kirkpatrick et al, 2001), renamed for use with patients as ‘stress-sensitivity psychosis’. Kraepelin’s inclusion of ‘hallucinating hysteria’ in dementia praecox has been reversed and, reinforced by the evidence of childhood trauma as a factor in some - particularly female - patients, has become ‘traumatic psychosis’. Paranoid states, variously described as late-onset paranoia, paranoid schizophrenia and delusional disorder - where systematised delusions develop in mature individuals experiencing stressful circumstances - has led to a revival of Wernicke’s term ‘anxiety psychosis’ (Healy, 2002). Finally, ‘drug-related psychosis’ which did not exist when ‘the group of schizophrenia’s’ was originally described, is recognised in its own right.

These terms have been found to be acceptable to both patients and clinical staff (Kingdon et al, 2008) and this study was developed to explore whether they might be less stigmatising than the term schizophrenia itself. Medical students were recruited as being readily accessible to the researchers and able to readily comprehend the requirements of the study. Another reason was that doctors have a seminal role in combating stigmatisation but their attitudes to psychiatry (Rajagopal et al, 2004) and people with mental health problems (Byrne, 1999) remain quite negative, which may affect their response to patients’ physical and psychological care (Thornicroft, 2006). We sought to test the hypothesis that the use of terminology based on psychosocial subgroups would lead to differences between these groups and schizophrenia, and that negative attitudes in respondents would be reduced.


arrow
Method
 
Medical students from the University of Southampton attending lectures about schizophrenia in their 2nd and 3rd years in 2005 were asked to complete the section of a questionnaire relating to schizophrenia which had been used to monitor the Royal College of Psychiatrists’ ‘Every Family in the Land’ campaign (Crisp et al, 2000). The questionnaire asked the respondent to ‘think of a person with schizophrenia’ and then rate them on a five-point scale on being dangerous to others: unpredictable; hard to talk to; have only themselves to blame; would improve if given treatment; feel the way we all do at times; will eventually recover fully and could pull themselves together if they wanted to. (Formal psychometric properties of the scale have not been published. Its validity could be said to have been established through the consensus process used in its development by the campaign.)

The students were also given brief descriptions of the psychosocial subgroups (Appendix) and asked to rate the individual groups against the same characteristics. Respondents were regarded as having a ‘negative opinion’ if they endorsed either of the two points on the five-point scale on the ‘negative’ side of its mid-point.

Data measured on a continuous scale were presented with mean, standard deviation and 95% confidence intervals. Normally distributed continuous data were analysed using one-way analysis of variance (ANOVA) and t-tests. Where data was skewed and non-normally distributed, non-parametric techniques (Kruskal-Wallis test and Mann-Whitney U-test) were applied. Categorical data were presented in percentages and association between categorical variables was assessed with the use of chi-squared test and where expected frequency were below five then the Fisher’s exact test was used. Statistical significant was assessed if P<0.05 and all analysis was conducted with the use of a statistical software SPSS version 14 for Windows.


arrow
Results
 
There were 241 medical students (66%) that took part in the survey from a possible 365 (the total number of 2nd and 3rd year students who could have attended the lectures); 16 questionnaires had missing data (in nine cases only the questionnaire on schizophrenia was completed). There were 160 females (66.4%); 79 students (32.8%) were less than 20 years old, 153 were between 20 and 30 years old (63.5%), and 8 were between 30 and 40 years old (3.3%); 178 were White (73.9%); 58 reported (24.1%) that they had known someone with schizophrenia prior to the survey. In comparison with previous studies using the same instrument in the general population (Crisp et al, 2004) and psychiatrists (Kingdon et al, 2004), the students’ attitudes were intermediate (Table 1).


View this table:
[in this window]
[in a new window]

 
Table 1. Respondents holding negative opinions about schizophrenia

The distribution of student attitudes towards schizophrenia and the subgroups markedly differed (Fig. 1). For schizophrenia, the distribution was normal. The drug-related group was similar but flattened and shifted towards higher values, whereas the other groups had a skewed distribution towards a lack of negative attitudes.


Figure 1
View larger version (29K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1. Distribution of negative attitudes.

Gender, ethnic group and age did not affect negative attitudes. The total negative attitude score was significantly greater towards schizophrenia than the subgroups overall (P<0.023). These also differentiated between schizophrenia and the individual subgroups with the exception of the trauma group. The sensitivity (P<0.001) and anxiety psychosis (P<0.001) subgroups were viewed more favourably, but the drug-related group was perceived more negatively (P<0.001). There were also significant differences in scores between schizophrenia and the subgroups on individual items (Table 2): 53% of respondents rated individuals with drug-induced psychosis as dangerous to others, which is significantly higher than for the other groups (Fig. 2). Furthermore, 35% of the respondents thought that individuals with schizophrenia would never recover, which was higher than for any of the subgroups.


View this table:
[in this window]
[in a new window]

 
Table 2. Negative attitudes to schizophrenia and subgroups


Figure 2
View larger version (17K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 2. Negative opinions of medical students to schizophrenia and psychosocial subgroups.


arrow
Conclusions
 
Use of psychosocial categories and terminology significantly reduced negative perceptions of medical students about people who comprise the group of schizophrenias. Most students exhibited some negative views towards schizophrenia. This was less towards the subgroups although a residual level of negative attitudes remained. The exception was the drug-related group where most held at least some negative views. There was concern about dangerousness and unpredictability with individuals who had misused hallucinogenic drugs and, as this is a major risk factor for aggression where it is associated with schizophrenia (Walsh et al, 2002), this may to some extent be justified. Overall, attitudes were substantially improved across most of the domains and in particular towards the possibility of recovery, even for the drug-related group. Evidence supporting the risk factors used to define the groups is substantial but there has been very limited research into differentiation between these individual groups in relation to prognosis, etc. There also needs to be debate about whether these are the most appropriate terms to use. For example, in response to a formal request from a carer organisation, the Japanese Society of Psychiatry and Neurology recently adopted the term ‘integration disorder’ for schizophrenia (Sato, 2006). Changing names of conditions has limitations in reducing stigma but there are few advocates, especially among patients themselves, for changing back from, for instance cerebral palsy, learning disability and bipolar disorder to spastic, retard or manic depressive.

The study does have significant limitations. As an ‘intervention’ to change attitudes, a randomised controlled approach would be more rigorous: the terms were not presented in a randomised way and this might have influenced the outcome. Also, as with many such health promotion studies, this investigation has been into declared attitudes and further work is needed to see if this is reflected in behaviour change and in the wider population where attitudes are more negative (Crisp, 2004) than in medical students.


arrow
Appendix
 
The person would typically describe their experience in the following way.

Drug-related psychosis

‘My problems started after I had taken speed (amphetamines), LSD, cocaine or a lot of cannabis. After that I started to get some problems and received treatment. The problems continued or came back after settling after the first time this happened. Eventually these problems were happening even when I did not take drugs.’

Anxiety psychosis

‘When I first received treatment for my problems, I had been having some hassle, stress, and so on, but had become convinced that there was a particular reason behind it all. Unfortunately, other people did not agree with me.’

Traumatic psychosis

‘My problems go back quite a way - maybe even as far as my childhood or soon after - and seem to have something to do with some very unpleasant experiences that I had. Now I seem to get unpleasant voices and maybe also visions - sometimes to do with these experiences.’

Stress-sensitivity psychosis

‘My problems began over a period of a few months or even a year or two. I became quite sensitive to stress which gradually led to interference with what I was doing. This led to increasing confusion and worry and eventually I received treatment. It was or has been difficult to get going again properly - however hard I try.’


arrow
References
 
  1. ANGERMEYER, M. C. & MATSCHINGER, H. (2005) Causal beliefs and attitudes to people with schizophrenia: trend analysis based on data from two population surveys in Germany. British Journal of Psychiatry,186, 331 -334.[Abstract/Free Full Text]
  2. BLEULER, E. (1911) Dementia Praecox or the Group of Schizophrenias. International University Press.
  3. BYRNE, P. (1999) Stigma of mental illness. Changing minds, changing behaviour. British Journal of Psychiatry, 174, 1 -2.[Free Full Text]
  4. CARPENTER, W. T., STRAUSS, J. S. & MULEH, S. (1973) Are there pathognomonic symptoms in schizophrenia? An empiric investigation of Schneider’s first-rank symptoms. Archives of General Psychiatry, 28, 847 -852.[Abstract/Free Full Text]
  5. CRISP, A., GELDER, M., RIX, S., et al (2000) Stigmatisation of people with mental illnesses. British Journal of Psychiatry, 177, 4 -7.[Abstract/Free Full Text]
  6. CRISP, A., GELDER, M., GODDARD, E., et al (2004) Stigmatisation of people with mental illnesses: a follow-up study withinthe Changing Minds campaign of the Royal College of Psychiatrists. World Psychiatry, 4, 106-113.
  7. HALL, W. (2006) Is cannabis use psychotogenic? Lancet, 367, 193 -195.[CrossRef][Medline]
  8. HEALY, D. (2002) The Creation of Psychopharmacology. Harvard University Press.
  9. KINGDON, D. & TURKINGTON, D. (2005) Cognitive Therapy of Schizophrenia. Guilford.
  10. KINGDON, D., SHARMA, T., & HART, D. (2004) What attitudes do psychiatrists hold towards people with mental illness? Psychiatric Bulletin, 28, 401 -406.[Abstract/Free Full Text]
  11. KINGDON, D., RAMON, S., PERKINS, R., et al (2006) Social inclusion for psychiatrists. In New Ways of Working for Psychiatrists. Final Report from National Steering Group. National Institute for Mental Health in England & Royal College of Psychiatrists.
  12. KINGDON, D. G., KINOSHITA, Y., NAEEM, F., et al (2007) Schizophrenia can and should be renamed. BMJ, 334, 221 -222.[Free Full Text]
  13. KINGDON, D., GIBSON, A., KINOSHITA, Y., et al (2008) Acceptable terminology and subgroups in schizophrenia: an exploratory study. Social Psychiatry and Psychiatric Epidemiology, 43, 239 -243.[CrossRef][Medline]
  14. KIRKPATRICK, B., BUCHANAN, R. W., ROSS, D. E., et al (2001) A separate disease within the syndrome of schizophrenia. Archives of General Psychiatry, 58, 165 -171.[Abstract/Free Full Text]
  15. KRAEPELIN, E. (1919) Dementia Praecox and Paraphrenia. Thoemmes Continuum.
  16. LIEBERMAN, J. A. & FIRST, M. B. (2007) Renaming schizophrenia. BMJ, 334, 108 .[Free Full Text]
  17. MYIN-GERMEYS, I., DELESPAUL, P. & VAN, O. J. (2005) Behavioral sensitisation to daily life stress in psychosis. Psychological Medicine, 35, 733 -741.[CrossRef][Medline]
  18. NATIONAL STATISTICS (2003) Attitudes to Mental Illness 2003: Report. Taylor Nelson Sofres (http://www.dh.gov.uk/assetRoot/04/07/91/16/04079116.pdf).
  19. RAJAGOPAL, S., REHILL, K. S. & GODFREY, E. (2004) Psychiatry as a career choice compared with other specialties: a survey of medical students. Psychiatric Bulletin, 28, 444 -446.[Abstract/Free Full Text]
  20. READ, J., AGAR, K., ARGYLE, N., et al (2003) Sexual and physical abuse during childhood and adulthood as predictors of hallucinations, delusions andthought disorder. Psychology and Psychotherapy: Theory, Research and Practice, 76, 1-22.[CrossRef]
  21. ROSS, C. A. & JOSHI, S. (1992) Schneiderian symptoms and childhood trauma in the general population. Comprehensive Psychiatry, 33, 269 -273.[CrossRef][Medline]
  22. SATO, M. (2006) Renaming schizophrenia: a Japanese perspective. World Psychiatry, 5, 53-55.[Medline]
  23. SCHNEIDER, K. (1959) Clinical Psychopathology (5th edn) (transl. M. W. Hamilton). Grune & Stratton.
  24. TESKEY, P. (2006) What’s in a name? A case for changing the ‘S’ word. Schizophrenia Digest, 4, 36 -37.
  25. THORNICROFT, G. (2006) Shunned. Discrimination against People with Mental Illness. Oxford University Press.
  26. WALSH, E., BUCHANAN, A. & FAHY, T. (2002) Violence and schizophrenia: examining the evidence. British Journal of Psychiatry, 180, 490 -495.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
DTBHome page
Cognitive behavioural therapy for schizophrenia
DTB, January 1, 2010; 48(1): 6 - 9.
[Abstract] [Full Text] [PDF]


Home page
Br. J. PsychiatryHome page
D. Kingdon, Y. Kinoshita, P. Hammersley, L. Hansen, S. Rathod, F. Naeem, and D. Turkington
Time to change concepts and terminology
The British Journal of Psychiatry, June 1, 2009; 194(6): 569 - 570.
[Full Text] [PDF]

eLetters:

Read all eLetters

Renaming Mental Disorders
Andrew Al-Adwani
The Psychiatrist Online, 23 Nov 2008 [Full text]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Kingdon, D.
Right arrow Articles by Turkington, D.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Kingdon, D.
Right arrow Articles by Turkington, D.